Huojian Shen
-
- Cancer-related molecular mechanisms research 2
- Cancer Genomics and Diagnostics 2
-
- Gallbladder and Bile Duct Disorders 2
-
- Pediatric Hepatobiliary Diseases and Treatments 2
- Cholangiocarcinoma and Gallbladder Cancer Studies 1
-
- Cancer Cells and Metastasis 2
- Peptidase Inhibition and Analysis 2
-
- RNA modifications and cancer 1
- Co-authors
- Hongyi ZhuFu JiChao YangKewei LiMing XuLi FuZhiyong ShenChao‐Chun Yang
- Journals
- Cell Death and Disease (2 papers)Pediatric Surgery International (1 paper)Asian Pacific Journal of Cancer Prevention (1 paper)
- Partner nations
- China
In The Last Decade
Huojian Shen
9 papers receiving 261 citations
Peers
Comparison fields: 5 of 45
- Cancer Research 77
- Pulmonary and Respiratory Medicine 125
- Surgery 137
- Oncology 59
- Molecular Biology 113
Countries citing papers authored by Huojian Shen
This map shows the geographic impact of Huojian Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huojian Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huojian Shen more than expected).
Fields of papers citing papers by Huojian Shen
This network shows the impact of papers produced by Huojian Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huojian Shen. The network helps show where Huojian Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huojian Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tracking of trastuzumab resistance in patients with HER2-positive metastatic gastric cancer by CTC liquid biopsy. | 2023 | 5 |
| 2 | 2022 | 1 | |
| 3 | 2021 | 42 | |
| 4 | 2020 | 42 | |
| 5 | 2015 | 76 | |
| 6 | 2015 | 47 | |
| 7 | Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine. | 2014 | 7 |
| 8 | 2014 | 6 | |
| 9 | 2012 | 38 |
About Huojian Shen
Huojian Shen is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 264 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (2 papers), Peptidase Inhibition and Analysis (2 papers), Gallbladder and Bile Duct Disorders (2 papers), Cancer-related molecular mechanisms research (2 papers), Cancer Genomics and Diagnostics (2 papers), Pediatric Hepatobiliary Diseases and Treatments (2 papers), RNA modifications and cancer (1 paper) and Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper). The work is most often cited by research in Cancer Research (77 citations), Pulmonary and Respiratory Medicine (125 citations) and Surgery (137 citations). Huojian Shen has collaborated with scholars based in China. Frequent co-authors include Hongyi Zhu, Fu Ji, Chao Yang, Kewei Li, Ming Xu, Li Fu, Zhiyong Shen, Chao‐Chun Yang, Yuanwen Chen and Jie Zhang. Their work appears in journals such as Cell Death and Disease, Pediatric Surgery International and Asian Pacific Journal of Cancer Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.